Peripheral "oscillatory" compliance is associated with aortic augmentation index

被引:74
作者
Segers, P
Qasem, A
De Backer, T
Carlier, S
Verdonck, P
Avolio, A
机构
[1] State Univ Ghent, Inst Biomed Technol, Hydrol Lab, B-9000 Ghent, Belgium
[2] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia
[3] Thorax Ctr Rotterdam, Rotterdam, Netherlands
关键词
compliance; arterial pressure; hypertension; arterial; blood pressure; aorta;
D O I
10.1161/01.HYP.37.6.1434
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The augmentation index (AIx) and "oscillatory" compliance (C-2) are wave contour analysis parameters for the central aorta (P-ao) and radial artery pressure wave (P-rad)(x) respectively. Both are sensitive to cardiovascular risk factors such as aging, hypertension, and diabetes and have been proposed as prognostic markers for cardiovascular disease. In this work, we studied the relation between both. We first calculated P-rad corresponding to a typical aortic A-type (AIx >0.15) and C-type wave (AIx <0), taken from the literature, by using a generalized aorta-radial pressure transfer function. P-rad corresponding to C-type waves yielded the highest C-2 value. We further used simultaneously measured aortic and radial artery pressure in 45 human subjects age 34 to 84 years (63 +/- 12 [SD]) at baseline and after administration of nitroglycerin to calculate AIx(meas) and C-2, respectively. Transfer function was used to calculate reconstructed aortic pressure and AIx(rec). AIx(rec) underestimates AIx(meas) by 0.03 +/-0.16, but both values correlate well (r=0.64; P<0.001). C-2 and AIx were inversely correlated (r=-0.36; P<0.001 for AIx(meas); r=-0.30; P <0.01 for AIx(rec)). Both AIx(meas) (0.06 +/-0.17 versus 0.20 +/-0.21; P <0.01) and AIx(rec) (0.04 +/-0.12 versus 0.16 +/-0.16; P<0.001) were lower after nitroglycerin, whereas C-2 increased only nonsignificantly (0.080<plus/minus>0.036 versus 0.071 +/-0.042). C-2 is related to AIx and reflects, at least in part, hemodynamic changes affecting central aortic pressure. Nevertheless, given the model assumptions and computational steps associated with calculating C-2, AIX could be a more appropriate parameter to use in the clinical setting because it is determined directly from the pressure wave contour.
引用
收藏
页码:1434 / 1439
页数:6
相关论文
共 16 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]   Augmentation of central arterial pressure in type 1 diabetes [J].
Brooks, B ;
Molyneaux, L ;
Yue, DK .
DIABETES CARE, 1999, 22 (10) :1722-1727
[3]   Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension [J].
Cameron, JD ;
McGrath, BP ;
Dart, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1214-1220
[4]  
Chen CH, 1997, CIRCULATION, V95, P1827
[5]   Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease [J].
Cohn, JN .
PROGRESS IN CARDIOVASCULAR DISEASES, 1999, 41 (06) :441-450
[6]   Fit to diastolic arterial pressure by third-order lumped model yields unreliable estimates of arterial compliance [J].
Fogliardi, R ;
Burattini, R ;
Schroff, SG ;
Campbell, KB .
MEDICAL ENGINEERING & PHYSICS, 1996, 18 (03) :225-233
[7]   ARTERIAL PRESSURE PULSE CONTOUR ANALYSIS VIA A MATHEMATICAL MODEL FOR CLINICAL QUANTIFICATION OF HUMAN VASCULAR PROPERTIES [J].
GOLDWYN, RM ;
WATT, TB .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1967, BM14 (01) :11-&
[8]   AN ANALYSIS OF THE RELATIONSHIP BETWEEN CENTRAL AORTIC AND PERIPHERAL UPPER LIMB PRESSURE WAVES IN MAN [J].
KARAMANOGLU, M ;
OROURKE, MF ;
AVOLIO, AP ;
KELLY, RP .
EUROPEAN HEART JOURNAL, 1993, 14 (02) :160-167
[9]   VASCULAR ABNORMALITIES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS IDENTIFIED BY ARTERIAL WAVE-FORM ANALYSIS [J].
MCVEIGH, G ;
BRENNAN, G ;
HAYES, R ;
COHN, J ;
FINKELSTEIN, S ;
JOHNSTON, D .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (04) :424-430
[10]  
McVeigh G E, 1993, Curr Opin Nephrol Hypertens, V2, P82, DOI 10.1097/00041552-199301000-00013